Newsroom

News

EU-OPENSCREEN is proud to present the second edition of the Autumn training school! For a whole week from November 14 to November 18, prestigious speakers from academia and industry will give talks on…

Read more

On September 19th, 2022, EU-OPENSCREEN and the Society for Laboratory Automation and Screening (SLAS) launched the 1st edition of the EU-OS/SLAS joint data mining challenge on the Kaggle competition…

Read more

Within the canSERV project EU-OPENSCREEN will focus on providing world-class services in the area of chemistry and drug discovery. The canSERV project, will make a wealth of services accessible…

Read more

EU-OPENSCREEN is one of the 10 partners in the AI4LIFE consortium coordinated by Euro-BioImaging ERIC, bringing together leading AI/ML researchers and developers of popular open source image analysis…

Read more

Get free access to our screening and medicinal chemistry services for your Monkeypox research project. ISIDORe just launched a call for transnational access for projects focusing on Monkeypox…

Read more

We are pleased to announce that from July 1st, 2022, Sweden expands the circle of EU-OPENSCREEN member countries from 9 to 10 countries. As a partner of EU-OPENSCREEN since the preparatory phase, our…

Read more

EU-OPENSCREEN Annual Report 2021 now online

EU-OPENSCREEN News

The EU-OPENSCREEN interactive Annual Report 2021 is now online. Enjoy reading about our developments and key achievements in 2021.

Read more

Would you like to learn more about the different funding opportunites within ISIDORe and the structure and research focus of ISIDORe? Then do not miss the upcoming webinar providing you with…

Read more

Within the recently launched ISIDORe transnational access call for proposals focusing on SARS-CoV-2 research EU-OPENSCREEN offers free of charge access opportunities to interested researchers to…

Read more

Our medicinal chemistry partner site, the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) in Berlin, Germany, has collaborated with 17 leading research institutions and pharma companies…

Read more